Palisade Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,962,999
Closed -$22.3M 387
2024
Q3
$22.3M Sell
1,962,999
-150,298
-7% -$1.71M 0.59% 67
2024
Q2
$15.1M Sell
2,113,297
-59,535
-3% -$425K 0.41% 85
2024
Q1
$14.6M Buy
2,172,832
+395,011
+22% +$2.65M 0.38% 92
2023
Q4
$11.6M Buy
1,777,821
+204,981
+13% +$1.33M 0.31% 105
2023
Q3
$14.8M Buy
1,572,840
+527,163
+50% +$4.98M 0.41% 86
2023
Q2
$14.6M Buy
1,045,677
+43,402
+4% +$606K 0.39% 90
2023
Q1
$18.8M Buy
1,002,275
+12,308
+1% +$231K 0.51% 69
2022
Q4
$13.6M Buy
989,967
+46,450
+5% +$640K 0.37% 90
2022
Q3
$18M Buy
943,517
+1,414
+0.2% +$27K 0.51% 64
2022
Q2
$14.4M Buy
942,103
+83,677
+10% +$1.28M 0.39% 84
2022
Q1
$17.5M Sell
858,426
-89,897
-9% -$1.83M 0.4% 86
2021
Q4
$27.7M Buy
948,323
+3,678
+0.4% +$107K 0.56% 61
2021
Q3
$20.4M Buy
944,645
+75,605
+9% +$1.63M 0.44% 78
2021
Q2
$22.3M Sell
869,040
-7,859
-0.9% -$202K 0.5% 67
2021
Q1
$16M Buy
+876,899
New +$16M 0.38% 99